Pinobio
Global Leading Biotech for
Novel Anticancer Treatment
Pinobio
Today's Curiosity will be
Tomorrow's Cure
Pinobio
A Revolutionary Approach
to Cancer Therapy
R&D
-
NTX-301
Best-in-class DNMT1 inhibitor targeted anticancer therapy in nucleoside-based drugs
-
PINOT-ADC™
Next-generation ADC anticancer drug platform technology that overcomes the limitations of existing ADC drugs
-
NTX-101
First-in-class eye drops that lower intraocular pressure and protect the optic nerve
IR&PR
What's New
Media
ADC Platform PINOT-ADC™ and
PBX-001 Mechanism of Action